Phenyl amino piperidine mTORC inhibitors and uses thereof
申请人:Navitor Pharmaceuticals, Inc.
公开号:US10414727B2
公开(公告)日:2019-09-17
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供了化合物、其组合物以及使用方法。
HETEROARYL UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS
申请人:Schering Corporation
公开号:EP1343503B1
公开(公告)日:2008-11-12
INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE
申请人:Centaurus Therapeutics
公开号:EP3737361A1
公开(公告)日:2020-11-18
Inhibitors of Dihydroceramide Desaturase For Treating Disease
申请人:Centaurus Therapeutics
公开号:US20200339535A1
公开(公告)日:2020-10-29
Disclosed herein are dihydroceramide desaturase 1 (Des1) inhibitor compounds and compositions, which are useful in the treatment of diseases, such as metabolic disorders, where inhibition of Des1 is expected to be therapeutic to a patient. Methods of inhibition of Des1 activity in a human or animal subject are also provided.
[EN] PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA PHÉNYL AMINO PIPÉRIDINE MTORC ET LEURS UTILISATIONS
申请人:NAVITOR PHARM INC
公开号:WO2018089499A1
公开(公告)日:2018-05-17
The present invention provides compounds, compositions thereof, and methods of using the same.